Advertisement

 

 

ESC Congress 2013

Author Information (click to view)

Christopher Cole

Senior Editor
Physician’s Weekly


Christopher Cole (click to view)

Christopher Cole

Senior Editor
Physician’s Weekly

Advertisement

New research is being presented at ESC Congress 2013, the annual meeting of the European Society of Cardiology, from August 31 to September 4 in Amsterdam, Netherlands.

Meeting Highlights

Women Benefit With Drug-Eluting Stents

Telemonitoring Detects Potential Issues With ICDs & CRT-Ds

Predicting Treatment Success in Atrial Fibrillation


News From the Congress

Record Number of Hot Line Submissions

Something Old, Something New. The Hokusai-VTE Study Suggests Certain Sub-Groups of Venous Thromboembolism Patients May Need Review

Results of the TASTE Trial Challenge Current Practice of Blood Clot Aspiration After Heart Attack

TAO Results End Hope for Otamixaban in NSTE-ACS

PARIS: Incidence and Impact of Dual Antiplatelet Therapy Cessation On Adverse Cardiac Events Following Percutaneous Coronary Intervention

Dabigatran Etexilate Is Contraindicated in Patients with Mechanical Heart Valves

LINC Study Finds Mechanical Chest Compressions Are Equally as Effective as Manual CPR

A Shorter Interruption of Anti-Thrombotics Does Not Influence Peri-Operative Complications in Cardiac Patients

Pre-Treatment with Prasugrel – More Risk, No Benefit: ACCOAST

Preventive PCI Results in Better Outcomes than Culprit Artery PCI Alone in ST Elevation MI

PURE: Contrasting Associations Between Risk Factor Burden, CVD Incidence and Mortality in High, Middle and Low Income Countries

Treatment with the Anti-Diabetic Drug Alogliptin Does Not Increase Cardiovascular Risk in Patients with Acute Coronary Syndromes

SAVOR-TIMI 53 Sets New Standard for Cardiovascular Outcome Trials in Diabetes

ASSURE: Effect of an Oral Agent Inducing Apo A-I Synthesis on Progression of Coronary Atherosclerosis

Common Blood Pressure Drug Reduces Aortic Enlargement in Marfan Syndrome

French Tour de France Cyclists Live Longer Than Their Non-Cyclist Countrymen

Despite Missing Primary Efficacy Endpoint, ATOMIC-AHF Identifies Positive Trends for Omecamtiv Mecarbil

Cardiac Resynchronization Therapy Offers No Benefit Beyond Implantable Cardioverter Defibrillator Therapy in Narrow-QRS Heart Failure Patients

AQUARIUS: Effect of the Renin Inhibitor Aliskiren on Progression of Coronary Atherosclerosis

Biomarker Assessment in Suspected Acute Coronary Syndrome Could be Practice-Changing: BIC-8 Results

 

More From the Congress

Registration

Hotel Bookings

Scientific Sessions

Schedule

Scientific Program

Final Program

Mobile Application

ESC Congress 365

Call for Science – Results

Exhibition and Industry

Travel and City

Your Attendance Guide

Welcome Address

Best of ESC Congress 2013

Past Congresses

Future Congresses

Submit a Comment

Your email address will not be published. Required fields are marked *

nineteen + 16 =

[ HIDE/SHOW ]